178 related articles for article (PubMed ID: 8567994)
1. Relation between stage, grade, proliferation, and expression of p53 and CD44 in adenomas and carcinomas of the colorectum.
Jackson PA; Green MA; Pouli A; Hubbard R; Marks CG; Cook MG
J Clin Pathol; 1995 Dec; 48(12):1098-101. PubMed ID: 8567994
[TBL] [Abstract][Full Text] [Related]
2. Expression of mdm2 and p53 in epithelial neoplasms of the colorectum.
Hao XP; Günther T; Roessner A; Price AB; Talbot IC
Mol Pathol; 1998 Feb; 51(1):26-9. PubMed ID: 9624416
[TBL] [Abstract][Full Text] [Related]
3. Proliferation and apoptosis in proliferative lesions of the colon and rectum.
Kikuchi Y; Dinjens WN; Bosman FT
Virchows Arch; 1997 Aug; 431(2):111-7. PubMed ID: 9293892
[TBL] [Abstract][Full Text] [Related]
4. Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas.
Kanavaros P; Stefanaki K; Valassiadou K; Vlachonikolis J; Mavromanolakis M; Vlychou M; Kakolyris S; Gorgoulis V; Tzardi M; Georgoulias V
Med Oncol; 1999 Apr; 16(1):23-30. PubMed ID: 10382939
[TBL] [Abstract][Full Text] [Related]
5. Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis.
Mulder JW; Wielenga VJ; Polak MM; van den Berg FM; Adolf GR; Herrlich P; Pals ST; Offerhaus GJ
Gut; 1995 Jan; 36(1):76-80. PubMed ID: 7534253
[TBL] [Abstract][Full Text] [Related]
6. Expression and clinicopathologic significance of TUFM and p53 for the normal-adenoma-carcinoma sequence in colorectal epithelia.
Xi HQ; Zhang KC; Li JY; Cui JX; Zhao P; Chen L
World J Surg Oncol; 2017 Apr; 15(1):90. PubMed ID: 28449687
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.
Baretton GB; Diebold J; Christoforis G; Vogt M; Müller C; Dopfer K; Schneiderbanger K; Schmidt M; Löhrs U
Cancer; 1996 Jan; 77(2):255-64. PubMed ID: 8625232
[TBL] [Abstract][Full Text] [Related]
8. Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma.
Bhatavdekar JM; Patel DD; Chikhlikar PR; Shah NG; Vora HH; Ghosh N; Trivedi TI
Dis Colon Rectum; 2001 Apr; 44(4):523-33. PubMed ID: 11330579
[TBL] [Abstract][Full Text] [Related]
9. Epithelial neoplasms of the appendix and colorectum: an analysis of cell proliferation, apoptosis, and expression of p53, CD44, bcl-2.
Carr NJ; Emory TS; Sobin LH
Arch Pathol Lab Med; 2002 Jul; 126(7):837-41. PubMed ID: 12088454
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of bcl-2 and p53 oncoproteins: correlation with Ki67 proliferation index and prognostic histopathologic parameters in colorectal neoplasia.
Saleh HA; Jackson H; Banerjee M
Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):175-82. PubMed ID: 10981868
[TBL] [Abstract][Full Text] [Related]
11. Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors.
Kusaba T; Nakayama T; Yamazumi K; Yakata Y; Yoshizaki A; Nagayasu T; Sekine I
J Clin Pathol; 2005 Aug; 58(8):833-8. PubMed ID: 16049285
[TBL] [Abstract][Full Text] [Related]
12. Expression of Bcl-2 and p53 in the colorectal adenoma-carcinoma sequence.
Hao XP; Ilyas M; Talbot IC
Pathobiology; 1997; 65(3):140-5. PubMed ID: 9309780
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of endoscopic biopsy using immunostaining of p53 and Ki-67 in tumors of the ampulla of Vater.
Kubota K; Kakuta Y; Kawamura S; Saito S; Seki H; Kuniyoshi T
Pathol Int; 2003 Jun; 53(6):361-70. PubMed ID: 12787310
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of p53 protein and histologic grades of dysplasia in colorectal adenomas.
Sameshima S; Kubota Y; Sawada T; Watanabe T; Kuroda T; Tsuno N; Higuchi Y; Shinozaki M; Sunouchi K; Masaki T; Saito Y; Muto T
Dis Colon Rectum; 1996 May; 39(5):562-7. PubMed ID: 8620809
[TBL] [Abstract][Full Text] [Related]
15. p53 Protein overexpression in colorectal tumors from patients with familial adenomatous polyposis: is it an early or late event?
Levi E; Stryker SJ; Rao MS
Am J Gastroenterol; 1996 Jan; 91(1):11-4. PubMed ID: 8561108
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of CD44: a useful independent predictor of prognosis in patients with colorectal carcinomas.
Bhatavdekar JM; Patel DD; Chikhlikar PR; Trivedi TI; Gosalia NM; Ghosh N; Shah NG; Vora HH; Suthar TP
Ann Surg Oncol; 1998 Sep; 5(6):495-501. PubMed ID: 9754757
[TBL] [Abstract][Full Text] [Related]
17. Prognostic evaluation of metallothionein expression in human colorectal neoplasms.
Ioachim EE; Goussia AC; Agnantis NJ; Machera M; Tsianos EV; Kappas AM
J Clin Pathol; 1999 Dec; 52(12):876-9. PubMed ID: 10711249
[TBL] [Abstract][Full Text] [Related]
18. p53 and CD44 as clinical markers of tumour progression in colorectal carcinogenesis.
Mulder JW; Wielenga VJ; Pals ST; Offerhaus GJ
Histochem J; 1997 Jun; 29(6):439-52. PubMed ID: 9248852
[TBL] [Abstract][Full Text] [Related]
19. p53 expression in colorectal tumors.
Purdie CA; O'Grady J; Piris J; Wyllie AH; Bird CC
Am J Pathol; 1991 Apr; 138(4):807-13. PubMed ID: 1707233
[TBL] [Abstract][Full Text] [Related]
20. Imbalance between proliferation and apoptosis in the development of colorectal carcinoma.
Hao X; Du M; Bishop AE; Talbot IC
Virchows Arch; 1998 Dec; 433(6):523-7. PubMed ID: 9870685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
